Lakewood-Amedex Biotherapeutics, Inc.
LABT
$3.14
-$0.34-9.77%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -95.05% | -64.09% | -48.10% | 165.93% | -29.97% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -43.62% | -42.40% | 127.76% | -28.92% | -20.34% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -83.43% | -60.76% | -41.09% | 139.76% | -28.81% |
|
|
|||||
| Total Current Assets | -83.43% | -60.76% | -41.09% | 139.76% | -28.81% |
| Net Property, Plant & Equipment | -18.14% | -15.27% | -13.17% | -11.57% | -10.31% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -4.71% | 0.00% | 0.00% | 0.00% |
| Total Assets | -59.24% | -51.11% | -36.78% | 90.50% | -23.60% |
|
|
|||||
| Total Accounts Payable | 43.78% | 36.66% | 250.69% | -62.20% | 26.31% |
| Total Accrued Expenses | 81.27% | 42.74% | -36.17% | 86.45% | 7.54% |
| Short-term Debt | 8.33% | 0.00% | 0.00% | 650.00% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.42% | 1.45% | 1.47% | 1.49% | 1.51% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 25.89% | 10.33% | 1.88% | 180.51% | 52.38% |
|
|
|||||
| Total Current Liabilities | 25.89% | 10.33% | 1.88% | 180.51% | 52.38% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 8.33% | 0.00% | 0.00% | 650.00% | -- |
| Capital Leases | -74.88% | -42.58% | -29.72% | -22.62% | -18.09% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 24.20% | 8.65% | 0.45% | 150.68% | 35.26% |
|
|
|||||
| Common Stock & APIC | 0.09% | 0.09% | 2.64% | 0.10% | 0.11% |
| Retained Earnings | -1.73% | -1.42% | -3.76% | -1.31% | -1.09% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -44.58% | -55.00% | -84.96% | -765.45% | -119.50% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -44.58% | -55.00% | -84.96% | -765.45% | -119.50% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -44.65% | -55.14% | -85.32% | -796.72% | -118.60% |
|
|
|||||